Current landscape of insomnia in managed care

American Journal of Managed Care

Volumn 13, Issue 11 SUPPL. 5, 2007, Pages

  Reeder, Claiborne E ^b   Franklin, Meg ^b   Bramley, Thomas J ^a  

^a XCENDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CLONIDINE; DECONGESTIVE AGENT; ESTAZOLAM; ESZOPICLONE; FLUOXETINE; FLURAZEPAM; IMIPRAMINE; LEVODOPA; METHYLDOPA; NON PRESCRIPTION DRUG; PHENELZINE; PHENYTOIN; PROPRANOLOL; PROTRIPTYLINE; QUAZEPAM; QUINIDINE; RAMELTEON; STEROID; TEMAZEPAM; THEOPHYLLINE; THYROID HORMONE; TRIAMTERENE; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE;

ARTICLE; BLURRED VISION; COGNITIVE THERAPY; COMORBIDITY; COST; DISEASE CLASSIFICATION; DRUG ABUSE; DRUG DEPENDENCE; HEALTH SERVICE; HUMAN; INSOMNIA; MEDICARE; PREVALENCE; PRIORITY JOURNAL; RELAXATION TRAINING; SEDATION; SIDE EFFECT; SLEEPING DIFFICULTY; XEROSTOMIA;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BENZODIAZEPINES; COMORBIDITY; COST OF ILLNESS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RECEPTORS, MELATONIN; SEX DISTRIBUTION; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES;

EID: 36849024460     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Doghramji K. The epidemiology and diagnosis of insomnia. Am J Manag Care. 2006;12(8 suppl):S214-S220.
2. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep. 2005;28:1049-1057.
3. Roth T, Boehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone. 2003;5:5-15.
4. Ancoli-lsrael S. The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness. Am J Manag Care. 2006;12(8 suppl):S221-S229.
5. Primary Insomnia. In: Medline Plus Medical Encyclopedia. Bethesda, MD: National Library of Medicine/National Institutes of Health; 2004. http://www.nlm.nih. gov/medlineplus/ency/article/000805.htm. Accessed August 28, 2007.
6. Goldberg LD. Managing insomnia in an evolving marketplace. Am J Manag Care. 2006;12(8 suppl):S212-S213.
7. National Sleep Foundation. 2003 Sleep in America Poll. http://www.kintera.org/atf/cf/{F6BF2668-A1B4-4FE8-8D1A-A5D39340D9CB}/ 2003SleepPollExec Summ.pdf. Accessed October 26, 2007.
8. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 1998;158:1099-1107
9. Walsh JK. Clinical and socioeconomic correlates of insomnia. J Clin Psychiatry. 2004;65(suppl 8):13-19.
10. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18:425-432.
11. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 1999;22(suppl 2):S366-S372.
12. Leigh TJ, Hindmarch I, Bird HA, Wright V. Comparison of sleep in osteoarthritic patients and age and sex matched healthy controls. Ann Rheum Dis. 1988;47:40-42.
13. McCrae CS, Lichstein KL. Secondary insomnia: diagnostic challenges and intervention opportunities. Sleep Med Rev. 2001;5:47-61.
14. Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (the SLEEPO study). Am J Kidney Dis. 1999;34:1089-1095.
15. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262:1479-1484.
16. McCall WV. A psychiatric perspective on insomnia. J Clin Psychiatry. 2001;62(suppl 10):27-32.
17. Taylor JR, Vazquez CM, Campbell KM. Pharmacologic management of chronic insomnia. South Med J. 2006;99:1373-1377.
18. Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev. 2006;10:7-18.
19. Kuppermann M, Lubeck DP, Mazonson PD, et al. Sleep problems and their correlates in a working population. J Gen Intern Med. 1995;10:25-32.
20. Zammit GK, Weinger J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep. 1999;22(suppl 2):S379-S385.
21. Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep. 2007;30:263-273.
22. Stoller MK. Economic effects of insomnia. Clin Ther. 1994;16:873-897; discussion 854.
23. Simon G, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 1997;154:1417-1423.
24. Chesson A Jr, Hartse K, Anderson WM, et al. Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2000;23:237-241.